COVID-19 Research

March 26, 2020

No items found.

‍Research funding opportunities related to COVID-19

On behalf of the Department of Health and Social Care, NIHR has established a single national process to prioritise and coordinate funding for COVID-19 research. This applies across all funded studies including public sector, industry and charity funding.

Information about this can be found here

Details of the process and the new single entry point can be found here

Application form is here

‍

UKRI Open Call – Research and innovation ideas to address COVID-19

IMI2 - Call 21 Development of therapuetics and diagnostics combatting coronavirus infections (closes 31 March 2020)

DASA COVID-19 Rapid sanitising technology for ambulances (closes 1st April 2020)

‍TechForce19 Supporting the elderley, vulnerable and self-isolating during COVID-19 (closes 1 April 2000)

LifeArc COVID-19 Development and testing of therapeutics (closes 6th April 2020)

Innovate UK Business-led innovation in response to global disruption (de minimis) (closes 17 April)

BSAC COVID-19 Supporting research projects (closes 17 April, simple application)

COVID-19 Therapeutics Accelerator Bill & Melinda Gates Foundation, Mastercard, Wellcome - contact: epidemics@wellcome.ac.uk for more infomation

Wellcome: Epidemic Preparedness COVID-19 (reviewing current proposals, may reopen)

‍

Are you researching COVID-19?

We love what all of our clients do. And we're always impressed by those working to tackle health care problems and save lives

So, at the moment we offer a FREE R&D Tax Credit Service for one year for organisations researching ways to tackle COVID-19 and its effects

We can also offer support with:

Identifying appropriate government support for your business
Bringing your year end forward so that you can file your R&D Tax Claim sooner
Free 1-2-1 support via the Innovate2succeed Programme
Plus a comprehensive range of other business support services
‍

‍Business Support Information

We've collated this list of links for businesses during this time

‍

We're here for an informal chat if you want to talk any of this through - just contact us using the details below

Call us on 01925 506100
Email us at info@inventya.com

Thanks for all that you're doing

‍

Image used in the header for this item:

Novel Coronavirus SARS-CoV-2. SEM showing SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19 emerging from the surface of cells (green) cultured in the lab.
Credit: NIAID-RML

Downloaded from here cropped to size

‍

March 26, 2020

← back to news

Consultancy

Bid Writing

Thank you! We will be in touch shortly.

Oops! Something went wrong while submitting the form.

Your privacy matters | View our privacy policy

More of our news

Top 5 Misconceptions About R&D Tax Relief

There are many misconceptions about Research and Development (R&D) Tax Relief, which can create confusion about who is eligible and what activities qualify. The scheme is designed to support businesses that address genuine scientific or technological uncertainty, but myths often make it difficult to understand the boundaries of eligibility.

October 16, 2025

Demystifying R&D Tax Relief: What Qualifies and What Doesn’t

R&D Tax Relief remains one of the most powerful ways for UK businesses to reclaim part of their innovation costs, but many SMEs struggle with one question: what actually qualifies?

October 1, 2025

Grant Reporting & Compliance: Avoiding Pitfalls Post-Funding

Winning a grant is an exciting milestone, but it’s not the end of the journey, it’s the beginning of a new responsibility. Once funding is awarded, funders expect clear evidence that their money is being spent responsibly and that the promised outcomes are being delivered. Many organisations focus heavily on the application stage but underestimate the importance of post-award compliance.

September 22, 2025

Why Early-Stage Startups Shouldn’t Ignore Grant Opportunities

In the startup world, funding is often synonymous with equity. Founders are conditioned to chase investors, prepare pitch decks, and give up shares to keep moving forward. But for many early-stage startups, this can come too soon and cost too much. What if there was a way to fund development, validate ideas, and gain credibility without parting with equity or rushing into a round? That’s exactly what innovation grants offer.

September 8, 2025

Building a Strong Consortium for Collaborative Grants

Collaborative grants open the door to larger, more ambitious innovation projects. But to succeed, funders want more than a good idea – they want the right team to deliver it. Strong consortia bring together diverse expertise, reduce risk, and demonstrate the project’s real-world impact. Whether you're an SME, academic institution, or R&D leader, knowing how to build and present a well-structured consortium can significantly boost your funding success.

August 25, 2025

R&D in Construction & Engineering: Overlooked Opportunities

While construction and engineering are typically seen as practical, hands-on sectors, they are also rich with technical innovation. Often, businesses in these sectors are unsure how to assess whether their projects meet HMRC’s eligibility criteria.

August 11, 2025

COVID-19 Research

March 26, 2020

‍Research funding opportunities related to COVID-19

Are you researching COVID-19?

So, at the moment we offer a FREE R&D Tax Credit Service for one year for organisations researching ways to tackle COVID-19 and its effects

Image used in the header for this item:

Novel Coronavirus SARS-CoV-2. SEM showing SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19 emerging from the surface of cells (green) cultured in the lab.
Credit: NIAID-RML

Downloaded from here cropped to size

More of our news

The latest funding, scale up and business growth tips, straight to your inbox

Commercial Services

Innovate UK Business Growth (previously Innovate UK EDGE)

Contact

Social Links

Other

COVID-19 Research

March 26, 2020

‍Research funding opportunities related to COVID-19

Are you researching COVID-19?

So, at the moment we offer a FREE R&D Tax Credit Service for one year for organisations researching ways to tackle COVID-19 and its effects

Image used in the header for this item:

Novel Coronavirus SARS-CoV-2. SEM showing SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19 emerging from the surface of cells (green) cultured in the lab. Credit: NIAID-RML

Downloaded from here cropped to size

More of our news

The latest funding, scale up and business growth tips, straight to your inbox

Commercial Services

Innovate UK Business Growth (previously Innovate UK EDGE)

Contact

Social Links

Other

Novel Coronavirus SARS-CoV-2. SEM showing SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19 emerging from the surface of cells (green) cultured in the lab.
Credit: NIAID-RML